Mattea Reinisch

机构：University of Mannheim, Heidelberg University, University Hospital Heidelberg, Frauenklinik Heidelberg, University Medical Centre Mannheim, Universitäts HNO Klinik Mannheim · ORCID：0000-0002-1381-8595

发表论文 199 篇 · 总被引 4705 次 · h-index 29

代表论文

• Targeting PI3K inhibitor resistance in breast cancer with metabolic drugs (2025 · Signal Transduction and Targeted Therapy · 被引 21)
• Therapy of early breast cancer: current status and perspectives (2025 · Archives of Gynecology and Obstetrics · 被引 20)
• Abstract GS3-05: NSABP B-59/GBG-96-GeparDouze: A randomized double-blind phase III clinical trial of neoadjuvant chemotherapy with atezolizumab or placebo followed by adjuvant atezolizumab or placebo in patients with Stage II and III triple-negative breast cancer (2025 · Clinical Cancer Research · 被引 16)
• AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2025 (2025 · Breast Care · 被引 16)
• AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025 (2025 · European Journal of Surgical Oncology · 被引 15)
• Chemotherapy-free neoadjuvant pembrolizumab combined with trastuzumab and pertuzumab in HER2-enriched early breast cancer (WSG-KEYRICHED-1): a single-arm, phase 2 trial (2025 · The Lancet Oncology · 被引 9)